Interventional procedure gives osteoarthritis patients years of pain relief

Interventional radiology procedures could represent a more minimally invasive pain relief option for patients struggling with osteoarthritis (OA) of the knee. 

Genicular artery embolization (GAE) targets synovial blood vessels in the leg that are believed to cause painful inflammation that contributes to the severe discomfort most patients experience with OA. It involves the insertion of a catheter into the arteries via a small incision in the hip. Tiny embolic agents flow through the catheter to the affected arteries, blocking them off, thus reducing pain and inflammation. The procedure is typically completed in an outpatient setting, taking around two hours with a similar recovery time. 

A new study in the Journal of Vascular and Interventional Radiology analyzed the long-term outcomes of patients who had undergone GAE to relieve their knee pain. Researchers found that they enjoyed relief for years after the procedure, prompting the team to suggest that GAE could represent a viable option for those who are not candidates for total joint replacement surgery. 

“Knee osteoarthritis is a leading cause of adult disability and, until now, most minimally invasive treatment options have been proven to provide only short-term relief, measured in weeks or months,” lead author Siddharth A Padia, MD, professor of radiology at UCLA Health, and colleagues noted. “For patients who are not candidates for knee replacement surgery, our study shows that GAE provides durable benefit to many patients, measurable for up to two years, a great leap forward in offering this cohort lasting relief.” 

The study included 40 patients with symptomatic, moderate to severe OA who had undergone GAE. One year post-procedure, 66% reported sustained relief; of those, 72% continued to experience a minimum 50% reduction in OA pain at the 24-month mark. None of the patients reported any adverse events. 

The procedure could be an effective, longer lasting alternative to other pain relief options, such as intraarticular corticosteroid injections, especially for individuals who are not candidates for total joint replacement surgery, the group suggested. 

“GAE is a promising therapeutic option for patients with osteoarthritis in the knee, allowing patients to return to their normal activities without lengthy recovery times,” said Padia. “We believe further investigation with larger cohorts and randomized controls should be conducted so we can validate these findings, refine patient selection and optimize the management of OA related knee pain.” 

New research also suggests that GAE may be more cost-effective than steroid injections as well. 

The study abstract can be found here. 

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She joined Innovate Healthcare in 2021 and has since put her unique expertise to use in her editorial role with Health Imaging.

Around the web

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

Trimed Popup
Trimed Popup